Intermountain Ventures, Canary Speech Partner to Improve Detection of Multiple Sclerosis
HIT Consultant
|
Contributed by: HeLOS Intelligence
Summary
Canary Speech, in partnership with Intermountain Ventures, is conducting a groundbreaking study to assess the feasibility of using vocal biomarkers to identify Multiple Sclerosis (MS). This study is noteworthy as it seeks to employ artificial intelligence to analyze vocal patterns, potentially transforming the diagnostic process for MS from invasive methods like MRI scans to a non-invasive voice analysis tool. If successful, this approach could significantly expedite early detection, improving outcomes for the 2.9 million individuals affected by MS worldwide. The research highlights the growing intersection of AI and healthcare technology, emphasizing the need for innovative solutions to streamline disease diagnosis.
